• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围手术期卵巢癌患者静脉血栓栓塞发生率的四种不同数据收集方法:马尼托巴卵巢癌结局(MOCO)组研究。

Perioperative Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Using Four Different Data Collection Methods: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study.

机构信息

Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB.

Department of Epidemiology, Cancer Care Manitoba, Winnipeg, MB; Cancer Care Manitoba Research Institute, Winnipeg, MB.

出版信息

J Obstet Gynaecol Can. 2022 May;44(5):475-481. doi: 10.1016/j.jogc.2021.10.010. Epub 2021 Oct 28.

DOI:10.1016/j.jogc.2021.10.010
PMID:34718149
Abstract

OBJECTIVE

To evaluate the incidence of venous thromboembolism (VTE) in 90-day pre-operative period and at 30 and 90 days post surgery in patients who underwent debulking for ovarian cancer, analyze the impact of extended prophylaxis that was initiated in 2012, and examine the influence of data collection technique on reported rates of VTE.

METHODS

This retrospective database and records study examined rates of VTE in epithelial ovarian cancer patients in Manitoba, Canada between 2004 and 2016. Cases of VTE were identified using ICD codes, drug prescriptions, and records reviews; 4 different data collection methods were used. Analysis was performed with analysis of variance, Kruskal-Wallis and χ tests, and interrupted time series models.

RESULTS

Data collection identified 823 debulking surgeries, with a final cohort of 779 patients; data were analyzed before and after extended prophylaxis intervention. Overall rates of VTE varied by collection method and were 1.82%-5.47%, 0.36%-3.16%, 0.85%-1.46%, and 1.46%-2.79%, respectively. During this timeframe, we noted a significant increase in the use of neoadjuvant chemotherapy (P = 0.010) and stage migration to stage 3 (P < 0.001).

CONCLUSION

We report the rates of VTE utilizing 4 different data collection methods. We found a low overall rate, with some trends requiring further investigation. This study highlights the importance of data collection method on the reported rates of VTE in research.

摘要

目的

评估行卵巢癌肿瘤细胞减灭术患者术前 90 天、术后 30 天和 90 天静脉血栓栓塞症(VTE)的发生率,分析 2012 年开始实施的延长预防方案的影响,并研究数据收集技术对报告 VTE 发生率的影响。

方法

本回顾性数据库和病历研究调查了 2004 年至 2016 年间加拿大马尼托巴省上皮性卵巢癌患者的 VTE 发生率。使用国际疾病分类(ICD)代码、药物处方和病历回顾来识别 VTE 病例;使用了 4 种不同的数据收集方法。采用方差分析、Kruskal-Wallis 和 χ 检验以及中断时间序列模型进行分析。

结果

数据收集共确定了 823 例肿瘤细胞减灭术,最终纳入了 779 例患者;在延长预防方案干预前后进行数据分析。VTE 的总体发生率因收集方法而异,分别为 1.82%至 5.47%、0.36%至 3.16%、0.85%至 1.46%和 1.46%至 2.79%。在此期间,我们注意到新辅助化疗的使用率显著增加(P=0.010),以及疾病分期向 3 期迁移(P<0.001)。

结论

我们利用 4 种不同的数据收集方法报告了 VTE 发生率。我们发现总体发生率较低,一些趋势需要进一步调查。本研究强调了数据收集方法对研究中报告 VTE 发生率的重要性。

相似文献

1
Perioperative Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Using Four Different Data Collection Methods: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study.围手术期卵巢癌患者静脉血栓栓塞发生率的四种不同数据收集方法:马尼托巴卵巢癌结局(MOCO)组研究。
J Obstet Gynaecol Can. 2022 May;44(5):475-481. doi: 10.1016/j.jogc.2021.10.010. Epub 2021 Oct 28.
2
Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.上皮性卵巢癌患者围手术期血栓栓塞事件的发生率及潜在预测因素。
Eur J Surg Oncol. 2020 May;46(5):855-861. doi: 10.1016/j.ejso.2020.01.026. Epub 2020 Jan 20.
3
Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer.上皮性卵巢癌肿瘤细胞减灭术后静脉血栓栓塞症的发生率及预测因素。
Int J Gynecol Cancer. 2013 Nov;23(9):1684-91. doi: 10.1097/IGC.0b013e3182a80aa7.
4
Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.韩国上皮性卵巢癌患者接受标准治疗后的静脉血栓栓塞发生率。
Cancer Med. 2021 Mar;10(6):2045-2053. doi: 10.1002/cam4.3797. Epub 2021 Feb 26.
5
Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.卵巢癌患者术后静脉血栓栓塞症的发生率及危险因素:系统评价和荟萃分析。
Gynecol Oncol. 2021 Feb;160(2):610-618. doi: 10.1016/j.ygyno.2020.11.010. Epub 2020 Nov 19.
6
Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.超越预防:卵巢癌初次减瘤手术后静脉血栓栓塞症的长期风险。
Gynecol Oncol. 2019 Feb;152(2):286-292. doi: 10.1016/j.ygyno.2018.11.021. Epub 2018 Nov 22.
7
Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.实施术后加速康复(ERAS)方案后卵巢癌患者一线治疗期间静脉血栓栓塞的风险
Gynecol Oncol. 2021 Aug;162(2):353-359. doi: 10.1016/j.ygyno.2021.05.032. Epub 2021 Jun 3.
8
Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.接受新辅助化疗的晚期上皮性卵巢癌患者静脉血栓栓塞症的发生率。
Int J Gynecol Cancer. 2020 Apr;30(4):491-497. doi: 10.1136/ijgc-2019-000980. Epub 2020 Feb 12.
9
Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?晚期卵巢癌患者接受新辅助化疗后静脉血栓栓塞症的发生率:是否需要进行血栓预防?
Gynecol Oncol. 2023 Sep;176:36-42. doi: 10.1016/j.ygyno.2023.06.577. Epub 2023 Jul 11.
10
Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?肥胖子宫内膜癌患者机器人辅助子宫切除术后静脉血栓栓塞的发生率:我们是否需要延长预防时间?
J Robot Surg. 2021 Jun;15(3):343-348. doi: 10.1007/s11701-020-01110-6. Epub 2020 Jun 26.